Byrna Technologies Inc. (BYRN), a Nasdaq-listed maker of non-lethal personal-defense launchers and less-lethal ammunition, has seen its share price collapse from a 52-week high near $30 to roughly $4. That steep drawdown makes one question especially pressing for investors: can BYRN stock reach the $8 level that current analyst price targets imply? The short answer is that the math is possible, but the required move is very large and the road is obstructed by a genuine business transition.
Analyst coverage of BYRN has thinned and turned more cautious as the stock fell. The three current, attributable targets reviewed are Roth Capital's $4.50 (Neutral, July 2026, downgraded from Buy), Craig-Hallum's $7.50 (Hold, April 2026, downgraded from Buy), and B. Riley Securities' $12.00 (Buy, July 2026, cut from $21). The arithmetic mean of these three figures is $8.00, rounded to a clean $8 central target. It is important to note this is not an official published consensus; it is a simple average of individual analyst price targets.
The $4.50-to-$12.00 range is strikingly wide — a reflection of how differently analysts weigh the same facts. Bullish firms point to wholesale and retail-channel growth plus a debt-free balance sheet, while more cautious analysts highlight weak direct-to-consumer sales, lower average order values, and slower dealer reorder activity. The dispersion itself is a signal: the market has not settled on whether 2026 is the bottom of a cycle or the beginning of a longer slide.
BYRN recently closed near $4.05 and slipped in pre-market trading after its fiscal third-quarter results. Reaching the $8 central target would require a gain of roughly 97% from that level — a very large move by any standard. The company's market capitalization is roughly $92 million, with trailing 12-month revenue near $109 million and a modest net loss.
For the three months ended August 31, 2026, Byrna reported net revenue of about $15.3 million, down 45.7% year over year, and a GAAP loss of $0.13 per share. Management attributed the decline to weaker e-commerce sales and slower reorder activity from dealers and chain stores following substantial restocking earlier in the fiscal year. Even so, CEO Conn Davis pointed to rising daily website sessions and sequentially improving conversion as early signs that new digital and media initiatives are taking hold. The path toward $8 would need those green shoots to translate into sustained revenue growth and a return to positive adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization).
Technically, BYRN sits far below its 200-day moving average near $8 — a level that now acts as overhead supply and happens to coincide almost exactly with the $8 central target. The 50-day moving average sits near $3.85, and the 52-week range spans roughly $3.17 to $30.62. The stock trades with a beta of about 1.7, meaning it is considerably more volatile than the broader market, and short interest is elevated at roughly 6% of shares outstanding (higher as a share of float). Any sustained move toward $8 would first need to reclaim and hold the $8 area, a zone that previously marked a major breakdown.
Analyst price targets generally reflect a research horizon of about 12 months, though the wide dispersion here suggests firms are modeling very different timelines for the turnaround. Investors focused on whether BYRN can reach $8 should watch quarterly revenue direction, gross margin and adjusted EBITDA, e-commerce conversion and average order value, wholesale and retail sell-through, and any further analyst target changes or rating revisions. Governance developments tied to the activist shareholder and management's ability to hold to guidance for a second-half improvement will also be pivotal.
For traders seeking a data-driven way to track stocks and ETFs like BYRN, Tickeron's AI Daily Buy/Sell Signals offer an additional lens. The tool uses artificial intelligence to continuously monitor thousands of stocks and exchange-traded funds, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover new opportunities, monitor existing positions, and spot shifting trends more efficiently than manual scanning alone. Explore AI Daily Buy/Sell Signals to see how automated monitoring can complement your own research.
The question of whether BYRN can reach $8 ultimately hinges on whether a deeply discounted, loss-making turnaround story can reignite revenue growth. The $8 central target — an average of analyst targets ranging from $4.50 to $12.00 — implies a roughly 97% gain from recent levels, which is a very large move requiring visible, sustained improvement. The balance sheet and channel-expansion strategy provide genuine support, while collapsing sales, ongoing losses, and a wide analyst disagreement argue for caution. The most telling near-term signals will be the direction of quarterly revenue, margin recovery, and whether the company's early conversion improvements persist. No price outcome is guaranteed, and investors should weigh both the upside implied by the target and the execution risk that has already forced repeated estimate cuts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, BYRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if BYRN jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To BYRN | 1D Price Change % | ||
|---|---|---|---|---|
| BYRN | 100% | -0.21% | ||
| AXON - BYRN | 36% Loosely correlated | +2.98% | ||
| AVAV - BYRN | 29% Poorly correlated | +0.16% | ||
| KTOS - BYRN | 29% Poorly correlated | -1.21% | ||
| RCAT - BYRN | 26% Poorly correlated | -4.59% | ||
| DFNS - BYRN | 25% Poorly correlated | +2.64% | ||
More | ||||